| 摘要 |
FIELD: chemico-pharmaceutical industry. ^ SUBSTANCE: the present innovation deals with applying the compound of formula I ^ ^ for treating neuropathic pains. This compound I (retigabin) is of high efficiency in treating allodynia, hyperalgesia-conditioned pains, neuropathic pain in case of diabetic neuropathy, neuropathic pain at migraine. The compound suggested is low toxic being of high bioavailability. ^ EFFECT: higher efficiency of therapy. ^ 6 cl, 1 tbl |
